The Cold Truth: Cryopreservation of Final Product in Cell Therapy Manufacturing
While using “fresh” final products (not designed for long-term storage) in cell therapy manufacturing is perfectly acceptable for proof of concept of the cell therapy, as development into late-stage and then commercial production becomes the goal, different constraints arise. This is where cryopreservation of final product becomes an option and, in some cases, even a necessity.
In this nine-page whitepaper you will learn:
- The benefits of cryopreservation of final product;
- The risks of cryopreservation;
- How to assess these benefits and risks in order to make informed business decisions regarding if-and when- to utilize cryopreserved final product as you work towards developing a commercially viable cell therapy.
Fill out the form to access your whitepaper!
